thidiazuron has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, EA; Ammar, RB; Ibrahim, HM; Ismail, MB | 1 |
| Al-Ramadan, SY; Al-Saeedi, FJ; Ben Ammar, R; Elsayed Mohamed, M; Islam, M; Rajendran, P | 1 |
2 other study(ies) available for thidiazuron and Breast Cancer
| Article | Year |
|---|---|
Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis.
Topics: Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Invasiveness; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Thiadiazoles; Tumor Cells, Cultured | 2021 |
Thidiazuron decreases epithelial-mesenchymal transition activity through the NF-kB and PI3K/AKT signalling pathways in breast cancer.
Topics: Biomarkers; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Survival; DNA Fragmentation; Epithelial-Mesenchymal Transition; Female; Humans; Immunohistochemistry; Matrix Metalloproteinases; NF-kappa B; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Protein Binding; Proto-Oncogene Proteins c-akt; Signal Transduction; Thiadiazoles | 2020 |